Belgium’s biotech sector consists of over 140 companies, represents 5% of European biotech firms, and 10,000 employees. In 2006, industry revenues totaled €3 billion ($4.65 billion). There are three main biotech regions. Flanders is home to 40 biotech companies. Over the last 10 years, approximately €36.3 million has been invested in the region’s biotech industry […]

Company Announcements SPEX SamplePrep is now the exclusive US distributor of Katanax Automated Electric Fluxers. Skyray Instrument entered the US market in March with four instruments, including the portable Pocket-II x-ray fluorescence spectrometer (XRF). Thermo Fisher Scientific added an optical emission and X-ray spectroscopy product demonstration center to its Training Institute in West Palm Beach, […]

Company Announcements Nacalai USA and Nano-C are developing an industrial-scale HPLC technology for the production of fullerenes and their chemical derivatives. Waters is integrating its Empower 2 software with ESA Bioscience’s Corona Charged Aerosol Detector. Hitachi High-Technologies and Waters agreed to develop and distribute an interface for Waters’ Empower 2 software and Hitachi’s LC systems. […]

San Diego, CA 6/5/08; Washington, DC 6/9/08—Beckman Coulter and Orchid Cellmark have filed a patent infringement suit against Sequenom in the US District Court of the Southern District of California. The suit alleges that Sequenom’s iPLEX products for SNP genotyping infringe three patents exclusively licensed to Beckman Coulter by Orchid Cellmark: US Patent No. 5,888,819 […]

This issue, IBO has made a couple of changes to its Life Science Sales Index. Beckman Coulter’s Life Science division, which includes the company’s centrifugation, life science automation and capillary electrophoresis-based systems, and Illumina were added to the Index. First-quarter 2008 Life Science Index sales grew 8.9% to $2,195 million compared to 9.7% growth in […]

Despite new economic data, investors appear to be increasingly mystified as to the actual condition of the economy. On May 20, the Federal Reserve lowered its 2008 growth forecast to 0.3%–1.2% from 1.3%–2.0%, citing inflation and unemployment concerns. Coupled with record-high crude oil prices of $135 a barrel and renewed liquidity concerns in the financial […]

In the face of slower spending by big pharma, weaker semiconductor spending and economic turmoil, calendar-year first-quarter revenues for major instrument and laboratory product companies stayed on track. First-quarter sales for 11 of the 13 companies profiled on pages 9–11 increased 11.8% in US dollars (see graph, page 10) (Affymetrix was excluded from the calculation […]

Gas chromatography (GC) has long been a primary analytical technique for analyzing petroleum-based fuels, but it is also used heavily in the rapidly developing biofuels industry. Petroleum-based fuels are a nonrenewable resource, and with the rapidly rising price of oil, the push to develop and expand the market for renewable biofuels is stronger than ever. […]

According to Ernst and Young’s “2008 Global Biotechnology Report,” global revenues from biotech companies increased 8% in 2007 to $84.8 billion. Global R&D expenditure increased 7% to $31.8 billion. Excluding the acquisition of Medimmune by AstraZeneca and Merck KGaA’s buyout of Serono, global revenue and R&D would have increased 17% and 26%, respectively. In the […]